Annual Total Liabilities
$41.82 M
-$42.74 M-50.54%
31 December 2023
Summary:
Repare Therapeutics annual total liabilities is currently $41.82 million, with the most recent change of -$42.74 million (-50.54%) on 31 December 2023. During the last 3 years, it has fallen by -$28.44 million (-40.48%). RPTX annual total liabilities is now -71.90% below its all-time high of $148.82 million, reached on 31 December 2019.RPTX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$31.43 M
-$237.00 K-0.75%
30 September 2024
Summary:
Repare Therapeutics quarterly total liabilities is currently $31.43 million, with the most recent change of -$237.00 thousand (-0.75%) on 30 September 2024. Over the past year, it has dropped by -$21.61 million (-40.74%). RPTX quarterly total liabilities is now -79.28% below its all-time high of $151.70 million, reached on 31 March 2020.RPTX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RPTX Total Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -50.5% | -40.7% |
3 y3 years | -40.5% | -59.4% |
5 y5 years | +15.2% | - |
RPTX Total Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -50.5% | at low | -69.6% | +1.0% |
5 y | 5 years | -71.9% | +15.2% | -79.3% | +1.0% |
alltime | all time | -71.9% | +15.2% | -79.3% | +1.0% |
Repare Therapeutics Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $31.43 M(-0.7%) |
June 2024 | - | $31.67 M(+1.7%) |
Mar 2024 | - | $31.13 M(-25.6%) |
Dec 2023 | $41.82 M(-50.5%) | $41.82 M(-21.2%) |
Sept 2023 | - | $53.04 M(-5.6%) |
June 2023 | - | $56.17 M(-34.0%) |
Mar 2023 | - | $85.06 M(+0.6%) |
Dec 2022 | $84.56 M | $84.56 M(-18.2%) |
Sept 2022 | - | $103.38 M(+25.3%) |
June 2022 | - | $82.53 M(+5.1%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $78.49 M(-2.2%) |
Dec 2021 | $80.29 M(+14.3%) | $80.29 M(+3.7%) |
Sept 2021 | - | $77.39 M(+2.4%) |
June 2021 | - | $75.56 M(+5.8%) |
Mar 2021 | - | $71.42 M(+1.6%) |
Dec 2020 | $70.26 M(-52.8%) | $70.26 M(+1.2%) |
Sept 2020 | - | $69.44 M(+2.0%) |
June 2020 | - | $68.08 M(-55.1%) |
Mar 2020 | - | $151.70 M(+1.9%) |
Dec 2019 | $148.82 M(+309.9%) | $148.82 M |
Dec 2018 | $36.31 M | - |
FAQ
- What is Repare Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Repare Therapeutics?
- What is Repare Therapeutics annual total liabilities year-on-year change?
- What is Repare Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Repare Therapeutics?
- What is Repare Therapeutics quarterly total liabilities year-on-year change?
What is Repare Therapeutics annual total liabilities?
The current annual total liabilities of RPTX is $41.82 M
What is the all time high annual total liabilities for Repare Therapeutics?
Repare Therapeutics all-time high annual total liabilities is $148.82 M
What is Repare Therapeutics annual total liabilities year-on-year change?
Over the past year, RPTX annual total liabilities has changed by -$42.74 M (-50.54%)
What is Repare Therapeutics quarterly total liabilities?
The current quarterly total liabilities of RPTX is $31.43 M
What is the all time high quarterly total liabilities for Repare Therapeutics?
Repare Therapeutics all-time high quarterly total liabilities is $151.70 M
What is Repare Therapeutics quarterly total liabilities year-on-year change?
Over the past year, RPTX quarterly total liabilities has changed by -$21.61 M (-40.74%)